ARTICLE | Finance
Seventure's microbiome plays
Why Seventure made Eligo its fifth microbiome investment from new fund
July 13, 2015 7:00 AM UTC
Seventure Partners' latest investment from its Health for Life Capital fund aims to harness the precision of CRISPR technology to preferentially eliminate harmful bacteria from the microbiome.
Seventure was the sole investor in Eligo Bioscience S.A.S.'s €2 million ($2.2 million) seed round. According to the firm's Isabelle de Cremoux, Eligo expects to raise an additional €1 million from angel investors, with the investments matched by non-dilutive grants to give the newco a total of €6 million...